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Abstract
To determine the extent of physiological variation of uptake of 18F-ﬂurodeoxyglucose (FDG) within palatine tonsils. To deﬁne normal
limits for side-to-side variation and characterize factors affecting tonsillar uptake of FDG.
Over a period of 16 weeks 299 adult patients at low risk for head and neck pathology, attending our center for FDG positron
emission tomography/computed tomography (PET/CT) scans were identiﬁed. The maximum standardized uptake value (SUVmax)
was recorded for each palatine tonsil. For each patient age, gender, smoking status, scan indication and prior tonsillectomy status as
well as weather conditions were noted.
There was a wide variation in palatine tonsil FDG uptake with SUVmax values between 1.3 and 11.4 recorded. There was a strong
left to right correlation for tonsillar FDG uptake within each patient (P< .01). The right palatine tonsil showed increased FDG uptake
(4.63) compared to the left (4.47) (P< .01). In multivariate analysis, gender, scan indication, and prevailing weather had no signiﬁcant
impact of tonsillar FDG uptake. Lower tonsillar uptake was seen in patients with a prior history of tonsillectomy (4.13) than those
without this history (4.64) (P< .01). Decreasing tonsillar FDG uptake was seenwith advancing age (P< .01). Signiﬁcantly lower uptake
was seen in current smokers (SUVmax 4.2) than nonsmokers (SUV 4.9) (P= .03).
Uptake of FDG in palatine tonsils is variable but shows a strong side-to-side correlation. We suggest the left/ right SUVmax ratio as
a guide to normality with a ﬁrst to 99th percentiles of (0.70–1.36) for use in patients not suspected to have tonsillar pathology.
Abbreviations: CT = computed tomography, FDG = ﬂurodeoxyglucose, kVp = kilovolts peak, mA = milliamperes, MBq =
megabequerels, PET = positron emission tomography, PET/CT = positron emission tomography/computed tomography, SUV =
standardized uptake value, SUVmax = maximum standardized uptake value.
Keywords: FDG, ﬂuorodeoxyglucose, laterality, normal variation, palatine tonsil, smoking, weather conditions1. Introduction
18F-Fluorodeoxyglucose (18F-FDG) is widely used throughout
the world as a tracer in positron emission tomography/computed
tomography (PET/CT) imaging to assess malignant and
nonmalignant diseases.[1] Many tissues have variable physiologi-
cal uptake of FDG and understanding the range of normal
variation and the factors contributing to that variation is helpful
in identifying pathology, as well as distinguishing this from
normal physiological variation. The palatine tonsils are paired
aggregations of lymphoid tissue between the palatoglossal and
palatopharygeal arches.[2,3]Editor: Nagabhushan Seshadri.
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1Given the normal defence function of lymphoid tissue of
Waldeyer’s ring, tonsillar tissue is normally in a variable state of
physiological inﬂammation. As increased uptake of FDG has
been described in a wide variety of infectious and inﬂammatory
disorders,[4] increased tracer uptake is to be expected, as is wide
variation between individuals.
Anatomic studies from tonsillectomies and postmortem studies
have shown the palatine tonsils are most prominent in childhood
and adolescence, undergoing atrophy throughout later adult
life.[5] The immune function and balance of B cell types also
changes with age.[6]
A number of studies have evaluated uptake of FDG within
palatine tonsils, mostly in the context of evaluating many other
structures. Such studies have shownmost patients have identiﬁable
increased uptake of FDG within the palatine tonsils and a wide
variation between individuals.[7–11] Many of these studies did not
speciﬁcally exclude patients with head and neck pathology.
A retrospective review of 78 patients has been undertaken
studying patients at low risk of focal head and neck pathology.[8]
Patients were routinely excluded if their blood glucose levels were
more than 11.1mmol/L. Within this population there was no
correlation between blood glucose and FDG uptake of the
palatine tonsils. The mean SUVmax was reported at 3.48 and a
negative correlation between advancing age and FDG uptake
within the palatine tonsils was described. A similar inverse
relationship between age and FDG uptake in palatine tonsils was
seen amongst patients known or suspected to have malignancy of
the head and neck.[12]
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asymmetry of tonsillar FDG uptake in the diagnosis of tonsillar
carcinoma. This study examined 43 control subjects with no
evidence of focal head and neck pathology, and 10 cases of
proven tonsillar carcinoma. An absolute 0.83 SUV difference
between the 2 sides was proposed as a possible predictor for
tonsillar malignancy.[13]
To our knowledge no previous study has evaluated the impact
on FDG uptake in palatine tonsils of prior tonsillectomy for
benign disease.
Lymphoma is a common indication for FDG PET/CT imaging.
Differentiating physiological from pathological tonsillar uptake
may be problematic in these patients. In post-therapy and
response to treatment scans, the 5-point scale or Deauville
scale[14] has been suggested and is widely used in both research
and clinical settings.[15] We are not aware of any study that has
systematically graded tonsillar uptake according to the 5-point
scale in “normal” subjects.
Upper respiratory tract infections are known to be more
common in periods of cold and wet weather.[16] In our center, as
in many others, consideration is given to delaying PET imaging
during episodes of acute infection. It is however possible that
higher tonsillar FDG uptake might be seen in colder, wetter
weather conditions. To our knowledge there has been no report
exploring correlations between weather conditions and tonsillar
FDG uptake.
The aim of this study was to evaluate the range of palatine
tonsil 18F-FDG uptake in a large cohort of patients in whom there
was no clinical or imaging evidence of focal upper respiratory
tract pathology. The hope was to give further guidance for a
reporting radiologist or physician in terms of a “cut off” beyond
which absolute uptake and in particular asymmetry should be
considered potentially abnormal and worthy of further investi-
gation. In terms of asymmetry, we sought to explore whether a
ratio or absolute side-to-side difference wasmoremeaningful.We
felt it was important to document the frequency of various grades
of uptake as deﬁned by the 5-point scale (Deauville criteria)
within the tonsils as this is of value in the context of interpreting
post-treatment scans in lymphoma. We aimed to systematically
evaluate the effect of age, gender, smoking status, a prior history
of tonsillectomy, scan indication, and prevailing weather
conditions on tonsillar uptake of FDG.2. Materials and methods
2.1. Patient selection
The study was based at the Wales Research and Diagnostic PET
Imaging Centre (PETIC) in Cardiff, UK. This tertiary referral
center serves a population of approximately 2.3 million. Since
December 2015, all adult patients attending our center for PET/CT
imaging for clinical purposes are invited to give written informed
consent for theuse of their scanand clinical data for the purposes of
research. The scheme has been granted ethical and local research
and development permissions and this allows us to perform
multiple observational studies without the need for further
individual permissions (PET tracer variations in health and disease
15/WA/0018). A study period between February 15, 2016 and
June 3, 2016 was selected (16 weeks). Patients having undergone
clinical FDG PET/CT imaging were identiﬁed from the hospital
radiology database. From the radiology database, the number of
patients giving and withholding consent was noted. Only data
from patients having given consent were further analyzed.2Patients aged 16 or over were considered for inclusion if they
had undergone a clinical FDG PET scan at our center during the
study period and had consented for the use of their data for
research. Patients were excluded if the scan was performed for the
assessment of known or suspected head and neck carcinoma or if
it became apparent that there was a previous history of head and
neck malignancy or previous radiotherapy to the head and neck
(34 patients). All patients with known or suspected lymphoma
were excluded (123 patients). Patients were excluded if the scan
data were incomplete or unavailable (3 patients) or if on viewing
the scan data it was felt that movement or misregistration made
accurate measurement of tonsillar FDG uptake impossible (5
patients). The exclusions left a total of 436 eligible patients. From
this group, a sample of 299 patient data sets was randomly
selected. This further selection was based on manual random
selection from the list without reference to any of the clinical or
scan data. Patients were selected evenly throughout the study
period with no particular bias towards time of day or date within
the study period. The selection was made blinded to all clinical
and demographic factors.2.2. Clinical data collection
A radiographer administered preimaging questionnaire was
reviewed for each included patient. From this, the following
data was extracted for each included patient; history of prior
tonsillectomy for benign disease, smoking history: This was the
patient’s self-reported smoking status either as a current smoker,
an ex-smoker, or a nonsmoker. From the radiology database, the
following data were ascertained: patient gender, age, scan date,
and indication. The imaging request form and report were also
scrutinized to look for any exclusion criteria.2.3. Meteorological data
Meteorological data (daily mean temperature and rainfall) were
provided by the UKMet Ofﬁce for the Bute Park Cardiff Weather
Station for the time period between February 15, 2016 and June
3, 2016 as an Excel spreadsheet (Met Ofﬁce, Fitzroy road, Exeter
EX2 7NL). The weather center is within 1.5 miles of our PET/CT
center, although many of our patients attended from a much
wider geographic area.2.4. PET/CT acquisition protocol
Patients were fasted for at least 6hours prior to tracer
administration. Serum glucose levels were routinely checked
and conﬁrmed to be less than 11.0mmol/L prior to proceeding
with imaging. Patients received a dose of 4 MBq of 18F-FDG per
kilogram of body weight. Uptake time was 90 minutes. 18F-
FDG PET/CT imaging was performed with a GE 690 PET/CT
scanner (GE Healthcare, Pollards Wood, Buckinghamshire,
UK). CT images were acquired in a helical acquisition with a
pitch of 0.98 and a tube rotation speed of 0.5 seconds. Tube
output was 120 kVp with output modulation between 20 and
200mA. Matrix size for the CT acquisition was 512  512
pixels with a 50cm ﬁeld of view. No oral or intravenous
contrast was administered. PET images were acquired at 3
minutes per ﬁeld of view. The length of the axial ﬁeld of view
was 15.7cm. Images were reconstructed with the ordered
subset expectation maximization algorithm, with 24 subsets
and 2 iterations. Matrix size was 256  256 pixels, using the
VUE Point time of ﬂight algorithm.
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All FDG PET CT images were reviewed by a trained observer
(EB) under direct supervision of three radiologists with at least 5
years of clinical PET/CT experience (PF, VSJ, and JR). Image
analysis was undertaken on a GE Xeleris workstation using
Volumetrics for PET/CT software version 2.1704. (GE health-
care, Pollards Wood, Buckinghamshire , UK.) A 2cm diameter
spherical region of interest was recorded for left and right
palatine tonsil (one measurement each side), mediastinal blood
pool and liver.
For measurement of palatine tonsils, the guidance was to
identify tissue in the lateral aspect of the oropharynx immediately
abutting the oropharyngeal cavity. Only laterally placed uptake
between the level of the soft palate to the epiglottis was recorded
and the 2cm spherical region of interest was placed over the most
avid part of the mucosal tissue here. Care was taken to avoid
physiological muscular uptake. Uptake cranial to the level of the
soft palate was not recorded. The PET and CT images were
analyzed side by side with the region of interest being placed on
the PET images.
For measurements of the mediastinal blood pool uptake, the
SUVmax was taken as the maximal uptake region acquired
within the lumen of the arch of the aorta. Care was taken to avoid
any physiological uptake from structures above and below the
aorta or metastases in the anterior mediastinum. For uptake
measurements in the liver, the SUVmax value was taken as a
region centrally in the right lobe of the liver, which did not
overlap with any liver metastases or avid physiological uptake by
bowel contents below the liver.
Uptake in the palatine tonsils was also categorized according to
the 5-point scale (14). For the purposes of this study, we have
deﬁned the categories as follows: (the 5-point scale itself has only
descriptive criteria for deﬁning grade 4 and grade 5 uptake)
Grade 1: no uptake, Grade 2: uptake but less than or equal to
mediastinal blood pool, Grade 3: uptake more than mediastinal
blood pool but less than or equal to liver, grade 4: uptake greater
than liver but not over twice liver and Grade 5: uptake more than
twice liver.2.6. Reproducibility sub study
To provide further assurance of the accuracy of the data
collection, a second observer (KM) independently made blinded
measurements of SUVmax for the left- and right-palatine tonsils,
mediastinal blood pool and liver for 20 randomly selected cases.
Interobserver reproducibility was assessed as set out in statistical
analysis.2.7. Statistical analysis
Patient demographics and pathology were summarized through
descriptive statistics. Left and right tonsil uptake were assessed by
Pearson’s correlation and compared by paired t-test and also
Wilcoxon signed rank test as sensitivity checking. Regression
models of average tonsillar uptake with forward/backward/
stepwise selection approaches were used to select signiﬁcant
factors from age, gender, smoking status and pathology
indication. Effect sizes of ﬁnal selected factors in the model,
with their associated 95% conﬁdence intervals and P-values were
reported. We also described the normal ranges of the left/right
tonsil uptake ratio via percentiles. The effect of weather
conditions on tonsillar uptake of FDG were tested by regression3models. The reproducibility of data collection are assessed
though inter-rater reliability analysis with calculated Intraclass
Correlation Coefﬁcient (ICC). IBM SPSS version 20 was used for
all analysis.3. Results and discussion
3.1. Patient characteristics
During the study period, 644 adult patients underwent clinical
body FDG PET-CT scans at our center. Of these 17 patients had
uncertain capacity or lacked capacity to consent and 26 patients
refused consent. This left 601 patients eligible for inclusion in the
study. This is an uptake/agreement rate of 93% suggesting that
most patients are happy for the use of anonymized data for
research purposes. Figure 1 outlines the patient selection and
exclusion process leading to a ﬁnal study population of 299.
Table 1 outlines the demographic characteristics of the 299
patients enrolled in the study. Of the 299 subjects, 167were male.
Themean age was 66with a range of 20 to 91 years. Just over half
of the patients (153, 51%) includedwere being imaged for known
or suspected lung malignancy. Colorectal carcinoma and
oesophageal malignancy were the other main indications for
imaging amongst our study population.3.2. Interobserver reliability of SUV measurements
Using the Intraclass Correlation Coefﬁcient, comparisons were
drawn between the two observers for 20 randomly selected
patients. The ICC values (left tonsil 0.98, right tonsil 1.0, MBP
0.85, liver 0.93) indicate high levels of inter-observer agreement
for all measurements. We have showed that measurements of
tonsillar FDG uptake are highly reproducible between blinded
observers.3.3. Normal ranges for SUVmax palatine tonsils
In our large cohort of patients, we have found a wide range of
uptake in the palatine tonsils. Figure 2 shows a representative
example of uptake in the palatine tonsils and a typical patient
with rather high symmetrical FDG uptake in the palatine tonsils.
The mean and (range) for uptake in the left palatine tonsil was
4.47 (1.3–10.7) and for the right 4.63 (1.4–11.4). The 5th and
95th percentiles for average tonsil SUVmax is 2.45 to 7.70.
3.4. Tonsillar symmetry and asymmetry
Figure 3 shows a scatter plot for the SUVmax of palatine tonsil
for all patients. The right and left tonsils show a close correlation
within individuals (Pearson’s correlation 0.92, P< .01). Figure 4
shows the left- and right-tonsil uptake to be roughly normal
distributed (with slight left skewness). On average, the right
palatine tonsil shows higher FDG uptake than the left, this is
conﬁrmed by the paired T test and The Wilcoxon Signed Ranks
Test (R>L=0.17 P< .01). This difference persists when patients
with a stated history of tonsillectomy are excluded (difference for
nontonsillectomy patients R>L 0.18 P< .01).
Interestingly, in the relatively smaller population of only 43
patients analyzed by Wong et al,[13] a higher SUVmax was
recorded for the right palatine tonsil compared to the left (R>L
0.14). The magnitude and direction of asymmetry whilst not
statistically signiﬁcant in the previous study is nonetheless nearly
exactly the same as seen here.
Figure 1. Patient selection ﬂowchart.
Table 1
Baseline characteristics of patients included in analysis.
Characteristic Descriptor Number %
Gender Male 167 56
Female 132 44
Age 20–30 years 4 1
30–40 years 5 2
40–50 years 21 7
50–60 years 44 15
60–70 years 102 34
70–80 years 101 33
80–90 years 21 7
Indication Lung 153 51
Oesophagus 55 18
Colorectal 42 14
Others 49 17
Smoking status Current smoker 64 21
Ex-smoker 152 51
Nonsmoker 74 25
Information unavailable 9 3
Tonsillectomy status Prior tonsillectomy 83 28
No prior tonsillectomy 207 69
Information unavailable or patient uncertain 9 3
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symmetrical, this is often not the case. The right lung has greater
volume and mass than the left[17] and right sided weight
dominance has been described for the right testis[18] and right
lobe of the thyroid gland.[19] There are also laterality differences
in incidence of cancer between paired organs.[20] The absolute
volume or mass of the palatine tonsils are very difﬁcult to
measure in any reliable way either on imaging or surgically. It is
nonetheless entirely plausible that the small SUVmax difference
seen here (R>L) simply reﬂects a greater average volume of the
right palatine tonsil.
There have been some suggestions that a complex relationship
between handedness, asymmetry in peripheral immunity, and
lateralization of infections and malignancy may exist.[21] The
slight asymmetry in metabolic activity of the palatine tonsils may
be an indirect sign of these complex interactions. Finally,
anatomic studies have shown systematic asymmetries in the
orientation of the laryngeal cartilaginous framework in adults,[22]
perhaps contributing to asymmetric measurements. Whilst these
issues might be interesting points for speculation, the key ﬁnding
Figure 2. Uptake of FDG in palatine tonsils. Axial FDGPET and fused PET/CT images at the level of the palatine tonsils showing symmetrical increased FDG uptake.
FDG=ﬂurodeoxyglucose, PET/CT=positron emission tomography/computed tomography.
Figure 3. Symmetry and correlation between FDG uptake in tonsils. Scatter plot for SUV max of left and right palatine tonsils for all patients. There is a wide variety
of FDG uptake between different patients but a close side-to-side correlation within each patient. FDG=ﬂurodeoxyglucose, SUVmax=maximum standardized
uptake value.
Figure 4. Distribution of SUVmax for palatine tonsils. It displays the frequency distribution of SUVmax for the left and right palatine tonsils. Both distributions are
nearly normally distributed with slight left skewness. SUVmax=maximum standardized uptake value.
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Figure 5. Scatter plots showing the relationship between average tonsillar SUVmax and (A) absolute measured left to right difference as well as (B) left: right ratio.
The side-to-side ratio appears to be more robust across the range of tonsillar FDG uptake. FDG=ﬂurodeoxyglucose, SUVmax=maximum standardized uptake
value.
Birkin et al. Medicine (2018) 97:24 Medicinefor PET reporters is that on average the right palatine tonsil has a
slightly higher SUVmax than the left, and this impact on the
normal ranges.
As shown in Figure 5A, higher absolute side-to-side variability
occurs at higher average tonsillar uptake values. Figure 5B shows
the ratio of L/R palatine tonsil SUVmax which is more evenly
distributed over the range of uptake values observed. The 1st to
99th percentiles for L/R SUVmax are 0.70 to 1.36, the 5th to 95th
percentiles 0.76–1.20 and 10th to 90th percentiles 0.81–1.14.
A previous study proposed an absolute side-to-side difference
of 0.83 SUV as a cut off for the range of side-to-side variation.[13]
Whilst this is a helpful suggestion, we suggest that it needs to be
nuanced in two respects: Firstly, any normal range must reﬂect
physiological tonsillar asymmetry (R>L). Secondly, we have
shown that over the range of tonsillar SUVmax, the side-to-side
ratio is better preserved than the absolute value difference
between the 2 sides. We recommend the side-to-side ratio as a
guide to identifying pathology.
In clinical practice, there are 2 distinct clinical scenarios: The
ﬁrst is the situationwhere the patient is not known or suspected to
have tonsillar pathology but asymmetric uptake is incidentally
noted on a scan performed for other reasons. In this circum-
stance, we would suggest that only exceptional asymmetry
should be reported and a L/R SUVmax ratio between 0.70 and
1.36 should be considered normal (1st–99th percentiles). On the
other hand, if tonsillar pathology is being actively sought, the
10th to 90th percentiles range might be considered (0.81–1.14).
Many factors will affect the judgment regarding whether to
report tonsillar asymmetry, including the ﬁndings on clinical
evaluation, other imaging studies and the side of the increased
tonsillar uptake in relation to involved lymph nodes. The ranges
of variation should however serve as some guide to the extent to
which any asymmetry is considered unusual or abnormal.3.5. Grade of uptake according to “5-point scale”
According to our interpretation of the 5-point scale the numbers
of patients with each of the Deauville grades of uptake were:
grade 1: 0, grade 2: 13 (4%), grade 3: 45 (15%), grade 4: 202
(68%), grade 5: 39 (13%). Using our deﬁnitions 81% of patients
either have grade 4 or grade 5 tonsillar FDG uptake. Great6caution should therefore be taken in suggesting the presence of
active tonsillar lymphoma on interim or end of treatment FDG
PET/CT scans. This point has already been stated in imaging
recommendations[15] and the current study acts as a reminder
that grade 4 or even grade 5 uptake in palatine tonsils should be
considered an entirely normal ﬁnding.
3.6. Effect of tonsillectomy for benign disease
Around 83 patients gave a prior history of tonsillectomy, 207
patients denied tonsillectomy, (9 patients status unknown). The
mean SUVmax for the tonsillectomy patients was 4.13 and for
patients denying tonsillectomy was 4.64 (P< .01).
We suggest that the simplest explanation for this is that
patients following tonsillectomy have a lower volume of
remaining tonsillar tissue and this therefore leads to lower
measured SUVmax values, presumably related to partial volume
effects. A prior history of tonsillectomy does not however alter
the slightly higher uptake in the right palatine tonsil nor the
degree of asymmetry between the sides (Fig. 6A and B). Previous
observational studies indicate a lower incidence of tonsillar
carcinoma in patients with a prior history of tonsillectomy,
presumably again due to a lower volume of remaining tonsillar
tissue.[23]
3.7. Effect of gender age and scan indication on tonsillar
FDG uptake
For further analysis, the mean palatine tonsillar uptake for each
patient ((left + right)/2) was assessed against the following
variables: gender, age, smoking status, and scan indication. Gender: The mean (SD) of tonsillar uptake of female patients
and male patients are 4.6 (1.5) and 4.5 (1.6), respectively. Two
sample T test suggests no difference across gender groups
(P= .82), a ﬁnding also seen in other observational stud-
ies.[8,12,13]
Age: Pearson’s correlation between age and average tonsillar
uptake is 0.36, which is signiﬁcant (P< .01). The negative
sign indicates a decreasing trend in tonsillar uptake in older
patients. This is displayed graphically in Figure 7. This ﬁnding
is compatible with other observational studies[8,12,13] and is in
Figure 6. Evaluation of the effect of tonsillectomy on tonsillar symmetry. Left–right tonsillar SUVmax difference plotted against frequency for the whole group (n=
299) (A) and for 209 patients with no prior history of tonsillectomy (B). SUVmax=maximum standardized uptake value.
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Birkin et al. Medicine (2018) 97:24 www.md-journal.comkeeping with the known reduction in size of the palatine tonsils
and the declining immune importance of the tonsils with
advancing age[24,25]
Scan indication: Amongst the 299 patients, 153 patients had
known or suspected lung cancer and 55 patients hadoesophageal cancer. Compared to other patients, neither those
with suspected lung (4.36 vs 4.67, P= .10), nor oesophageal
cancer (4.90 vs 4.67, P= .42) had signiﬁcantly different levels
of FDG uptake.
Gender, age, smoking status, and pathology indication were
considered initially for regression analysis on average tonsillar
uptake. After applying variable selection approaches, in the ﬁnal
model, age, and current smoking status were both conﬁrmed to
be associated with lower uptake of FDG in the palatine tonsils
(Table 2). In the ﬁnal model gender and scan indication had no
effect of palatine tonsil FDG uptake.3.8. Smoking status and tonsil FDG uptake
ANOVA analysis shows that there are signiﬁcant differences
(P= .02) in average tonsillar FDG uptake between smokers and
nonsmokers. The mean tonsillar SUVmax for nonsmokers was
4.9, whereas in current smokers the mean tonsillar SUVmax was
4.2. Patients identifying themselves as ex-smokers had interme-gure 7. Relationship of age to tonsillar FDG uptake. Bar graph dividing
tients into decade age groups, and displaying average SUVmax for each
oup. There were no patients under the age of 20 in the study. FDG=
rodeoxyglucose, SUVmax=maximum standardized uptake value.
7diate SUVmax values of 4.4 (not signiﬁcantly different from the
other groups).
Smoking has a complex effect on the immune system. Whilst
many inﬂammatory processes are triggered by tobacco smoke,
some elements of defensive immunity are suppressed by both
tobacco generally and nicotine speciﬁcally).[26,27] A pilot study of
tonsillectomy specimens in smokers and nonsmokers revealed a
variety of histological differences.[28] We propose that the
reduced FDG uptake demonstrated in smokers reﬂects overall
suppression of tonsillar immune function.3.9. Weather conditions and tonsillar FDG uptake
For this analysis, mean temperature and rainfall on the scan date,
adjusted with age and smoking status were assessed. The results
indicate no effect of temperature or rainfall on tonsillar FDG
uptake. These results are displayed graphically in Figure 8. The
weekly average mean temperature at the beginning of the period
was only 4°C, rising steadily to 16°C by the end of the study
period indicating a signiﬁcant variation over the study period. It
seems unlikely that there is any major seasonal variation in
tonsillar FDG uptake.
3.10. Patient selection: how “normal” is our population?
In this study, we have attempted to describe the range of normal
variation of FDG in palatine tonsils. Our assumption is that none
of our patients had focal tonsillar pathology. This is, of course,
not necessarily the case and to prove this beyond doubt all of the
patients would have to have a comprehensive clinical ENT
examination which would be impractical and unethical. The
most fundamental challenge with this type of study is that of
patient selection. Nearly all of our clinical FDG PET/CT scansTable 2
Final model indicating signiﬁcant factors associated with tonsillar
FDG uptake.
Effect size Lower 95% CI Upper 95% CI P-value
Age 0.05 0.06 0.03 <.01
Current smoker
∗ 0.51 0.97 0.04 .03
Ex-smoker
∗ 0.09 0.49 0.31 .66
FDG= ﬂurodeoxyglucose.
∗
non smoker is the baseline status.
Figure 8. Weather parameters and tonsillar FDG uptake grouped on a weekly basis. (A) Displays average tonsillar SUVmax values for each of 16 weeks plotted
against mean temperature throughout the study period. Whilst the temperature rises during the period from February to June there is no obvious change in tonsillar
FDG uptake. (B) It shows rainfall averaged over a weekly basis of the 16-week study period. FDG=ﬂurodeoxyglucose, SUVmax=maximum standardized uptake
value.
Birkin et al. Medicine (2018) 97:24 Medicinewere performed either in people with cancer or persons suspected
to have cancer. None of our patients are therefore “normal.” The
question then arises as to how many patients to exclude and the
choice of exclusion criteria. We feel however that we have taken
reasonable steps to exclude patients at high risk of focal tonsillar
pathology. We did not speciﬁcally exclude patients with
oesophageal malignancy or lung cancer however; within our
population these groups did not differ from the remainder in
terms of the level of tonsillar FDG uptake. Our mean values for
pharyngeal tonsil uptake are very similar to those reported
previously using more rigorous exclusions[13] (left 4.68 and right
4.82). It therefore seems unlikely that we are systematically
including signiﬁcant numbers of people with focal tonsil
pathology in our population.4. Conclusion
There is a wide variation in FDG uptake in the palatine tonsils but
a striking side-to-side correlation within each patient. Uptake
time and scanner conﬁguration may have effects on FDG uptake
and given these and the wide range of variation in our population
we suggest that the left/right tonsillar SUVmax ratio is a much
more robust andwidely applicable parameter than absolute levels
of FDG uptake or absolute differences in FDG uptake.
We propose left/right SUVmax ratios as a guide to identify
pathology rather than any absolute value for SUVmax.8Advancing age, current smoking status, and previous
tonsillectomy are all correlated with lower levels of FDG
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